Ferric carboxymaltose: all 159 studies that test it
Page 2 of 2. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.
- Effect of Postoperative Ferric CarboxymaltoseStatus unknownNCT03561480Phase 4
- A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency AnemiaCompletedNCT03399084Phase 1
- Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKDStatus unknownNCT03388385Phase 4
- Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization TherapyCompletedNCT03380520Phase 4
- Effect of Iron on Cerebral Dopamine Receptor Density in Non-anaemic Premenopausal Women With Low Ferritin and FatigueStatus unknownNCT03305705Phase 4
- Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control TrialStatus unknownNCT03295851Phase 4
- A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.TerminatedNCT03191201Phase 4
- Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiencyCompletedNCT03079518Phase 2
- Effect of IV Iron in Patients With Heart Failure With Preserved Ejection FractionCompletedNCT03074591Phase 4
- Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise TrialStatus unknownNCT03050424Phase 2
- Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron DeficiencyWithdrawnNCT03042130Phase 4
- Iron Long-Term Labelling Study SwitzerlandStatus unknownNCT02979132Not applicable
- The Effect of Ferric Carboxymaltose on Hemoglobin and Blood Transfusion in Cardiac SurgeryStatus unknownNCT02939794Phase 4
- Intravenous Iron Pre-treatment in Prognathic SurgeryStatus unknownNCT02800746Not applicable
- Iron Stores and Skeletal Muscle Metabolism in Chronic Heart FailureCompletedNCT02737995Phase 1
- Intravenous Iron for Treatment of Anaemia Before Cardiac SurgeryCompletedNCT02632760Phase 4
- Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating PancreatoduodenectomyCompletedNCT02628860Phase 2
- The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer PatientsStatus unknownNCT02599012Phase 2
- Does Intraoperative Intravenous Iron Enhance Postoperative Oxygenation Profile in Total Knee Arthroplasty Surgery?CompletedNCT02544464Phase 4
- IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in TanzaniaStatus unknownNCT02541708Phase 3
- Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic FatigueStatus unknownNCT02517151Phase 2
- Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.CompletedNCT02469480Phase 2
- Iron Status and Human MetabolismCompletedNCT02308449Not applicable
- Optimizing Iron Suppletion After Roux-en-Y Gastric BypassCompletedNCT02271997Phase 4
- Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of AnaemiaStatus unknownNCT02243735Phase 4
- Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)CompletedNCT02232906Phase 4
- Intravenous Iron: Measuring Response in Anemic Surgical PatientsCompletedNCT02057471Phase 4
- Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.CompletedNCT02031289Phase 4
- Randomized Study Comparing Ferric Carboxymaltose to Iron Sucrose to Treat Fe Deficiency in the Surgically Critically IllWithdrawnNCT02009943Phase 1
- Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric CarboxymaltoseTerminatedNCT01978028Phase 4
- Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart FailureCompletedNCT01922479Phase 4
- Comparing Intravenous and Oral Iron in Postoperative AnemiaCompletedNCT01913808Phase 4
- Iron Status and Hypoxic Pulmonary Vascular ResponsesCompletedNCT01847352Not applicable
- Iron in Congestive Heart FailureTerminatedNCT01837082Phase 3
- Intravenous High Dose Iron in Blood DonorsCompletedNCT01787526Phase 3
- Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)CompletedNCT01725789Phase 3
- IVICA: Intravenous Iron in Colorectal Cancer Associated AnaemiaCompletedNCT01701310Phase 4
- Preoperative Intravenous Iron to Treat Anaemia in Major SurgeryCompletedNCT01692418Phase 3
- Efficacy of Parenteral Iron Supplementation After Gastrointestinal Bleeding in Subjects Over 65CompletedNCT01690585Phase 3
- Iron Substitution in Blood DonorsCompletedNCT01519830Phase 4
- Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron DeficiencyCompletedNCT01513369Phase 3
- A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron DeficiencyCompletedNCT01453608Phase 4
- Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart FailureCompletedNCT01394562Phase 3
- Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance in Premenopausal WomenCompletedNCT01374776Phase 4
- Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic SurgeryTerminatedNCT01345968Phase 4
- Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of PregnancyCompletedNCT01245777Phase 4
- Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative PeriodCompletedNCT01154491Phase 3
- Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant WomenCompletedNCT01131624Phase 3
- Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing AgeCompletedNCT01110356Phase 4
- Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing ChemotherapyCompletedNCT01101399Phase 3
- Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving ChemotherapyTerminatedNCT01100879Phase 4
- Iron Substitution After Upper Gastro-Intestinal BleedingCompletedNCT00978575Phase 4
- Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum AnemiaTerminatedNCT00929409Phase 2/3
- Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)TerminatedNCT00882414Phase 2
- EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart FailureTerminatedNCT00821717Phase 3
- FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-CORCompletedNCT00810030Phase 3
- Maintenance Treatment of Iron Deficiency in IBD PatientsCompletedNCT00810004Phase 3
- Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic SurgeryTerminatedNCT00706667Phase 4
- Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)CompletedNCT00520780Phase 3